Top JPMorgan banker sees steady supply of Chinese health care IPOs, even as investors flag valuation concerns

China’s health care industry, the world’s second largest, will see a sustained increase in stock offerings after registering record-high transactions and valuations in 2020, a senior JPMorgan Chase …
( read original story …)

---